275 related articles for article (PubMed ID: 37633909)
1. Glutathione Peroxidase 3 induced mitochondria-mediated apoptosis via AMPK /ERK1/2 pathway and resisted autophagy-related ferroptosis via AMPK/mTOR pathway in hyperplastic prostate.
Li Y; Zhou Y; Liu D; Wang Z; Qiu J; Zhang J; Chen P; Zeng G; Guo Y; Wang X; DiSanto ME; Zhang X
J Transl Med; 2023 Aug; 21(1):575. PubMed ID: 37633909
[TBL] [Abstract][Full Text] [Related]
2. NELL2 modulates cell proliferation and apoptosis via ERK pathway in the development of benign prostatic hyperplasia.
Liu J; Liu D; Zhang X; Li Y; Fu X; He W; Li M; Chen P; Zeng G; DiSanto ME; Wang X; Zhang X
Clin Sci (Lond); 2021 Jul; 135(13):1591-1608. PubMed ID: 34195782
[TBL] [Abstract][Full Text] [Related]
3. SIRT3 deficiency is resistant to autophagy-dependent ferroptosis by inhibiting the AMPK/mTOR pathway and promoting GPX4 levels.
Han D; Jiang L; Gu X; Huang S; Pang J; Wu Y; Yin J; Wang J
J Cell Physiol; 2020 Nov; 235(11):8839-8851. PubMed ID: 32329068
[TBL] [Abstract][Full Text] [Related]
4. Upregulated bone morphogenetic protein 5 enhances proliferation and epithelial-mesenchymal transition process in benign prostatic hyperplasia via BMP/Smad signaling pathway.
Liu D; Liu J; Li Y; Liu H; Hassan HM; He W; Li M; Zhou Y; Fu X; Zhan J; Wang Z; Yang S; Chen P; Xu D; Wang X; DiSanto ME; Zeng G; Zhang X
Prostate; 2021 Dec; 81(16):1435-1449. PubMed ID: 34553788
[TBL] [Abstract][Full Text] [Related]
5. Simvastatin Improves Benign Prostatic Hyperplasia: Role of Peroxisome-Proliferator-Activated Receptor-γ and Classic WNT/β-Catenin Pathway.
Wang Z; Yang S; Li Y; Zhou Y; Liu D; Liu J; DiSanto ME; Zhang X
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902342
[TBL] [Abstract][Full Text] [Related]
6. Glucose-regulated protein 78 modulates cell growth, epithelial-mesenchymal transition, and oxidative stress in the hyperplastic prostate.
Fu X; Liu J; Liu D; Zhou Y; Guo Y; Wang Z; Yang S; He W; Chen P; Wang X; DiSanto ME; Zhang X
Cell Death Dis; 2022 Jan; 13(1):78. PubMed ID: 35075122
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of RhoA regulating benign prostatic hyperplasia: RhoA-ROCK-β-catenin signaling axis and static & dynamic dual roles.
Shan S; Su M; Li Y; Wang Z; Liu D; Zhou Y; Fu X; Yang S; Zhang J; Qiu J; Liu H; Zeng G; Chen P; Wang X; DiSanto ME; Guo Y; Zhang X
Mol Med; 2023 Oct; 29(1):139. PubMed ID: 37864185
[TBL] [Abstract][Full Text] [Related]
8. SIRT3 affects mitochondrial metabolic reprogramming via the AMPK-PGC-1α axis in the development of benign prostatic hyperplasia.
Li Y; Wang Q; Li J; Shi B; Liu Y; Wang P
Prostate; 2021 Nov; 81(15):1135-1148. PubMed ID: 34411320
[TBL] [Abstract][Full Text] [Related]
9. The Prostate-Associated Gene 4 (PAGE4) Could Play a Role in the Development of Benign Prostatic Hyperplasia under Oxidative Stress.
Li Y; Liu J; Liu D; Wang Z; Zhou Y; Yang S; Guo F; Yang L; Zhang X
Oxid Med Cell Longev; 2022; 2022():7041739. PubMed ID: 35633887
[TBL] [Abstract][Full Text] [Related]
10. Traditional Chinese Medicine Danzhi qing'e decoction inhibits inflammation-associated prostatic hyperplasia via inactivation of ERK1/2 signal pathway.
Liu Y; Shao R; Suo T; Zhu J; Liu E; Wang Y; Miao L; Gao X
J Ethnopharmacol; 2023 Jun; 309():116354. PubMed ID: 36906158
[TBL] [Abstract][Full Text] [Related]
11. S100A4 modulates cell proliferation, apoptosis and fibrosis in the hyperplastic prostate.
Yang L; Liu J; Yin J; Li Y; Liu J; Liu D; Wang Z; DiSanto ME; Zhang W; Zhang X
Int J Biochem Cell Biol; 2024 Apr; 169():106551. PubMed ID: 38360265
[TBL] [Abstract][Full Text] [Related]
12. STEAP4 modulates cell proliferation and oxidative stress in benign prostatic hyperplasia.
Liu J; Zhou W; Yang L; Li Y; Qiu J; Fu X; Ren P; Guo F; Zhou Y; Liu J; Chen P; DiSanto ME; Zhang X
Cell Signal; 2024 Jan; 113():110933. PubMed ID: 37866665
[TBL] [Abstract][Full Text] [Related]
13. Low-dose hypomethylating agents cooperate with ferroptosis inducers to enhance ferroptosis by regulating the DNA methylation-mediated MAGEA6-AMPK-SLC7A11-GPX4 signaling pathway in acute myeloid leukemia.
Feng S; Yuan Y; Lin Z; Li M; Ye D; Shi L; Li D; Zhao M; Meng C; He X; Wu S; Xiong F; Ye S; Yang J; Zhuang H; Hong L; Gao S
Exp Hematol Oncol; 2024 Feb; 13(1):19. PubMed ID: 38378601
[TBL] [Abstract][Full Text] [Related]
14. Activating autophagy and ferroptosis of 3‑Chloropropane‑1,2‑diol induces injury of human umbilical vein endothelial cells via AMPK/mTOR/ULK1.
Yi X; Long X; Liu C
Mol Med Rep; 2023 Mar; 27(3):. PubMed ID: 36799162
[TBL] [Abstract][Full Text] [Related]
15. GPX3-Mediated Oxidative Stress Affects Pyrimidine Metabolism Levels in Stomach Adenocarcinoma via the AMPK/mTOR Pathway.
Zhang Y; Yang Y; Kuang S; Zhang Y; Qin H; Xie J
Int J Clin Pract; 2024; 2024():6875417. PubMed ID: 38322113
[TBL] [Abstract][Full Text] [Related]
16. ALOX5 promotes autophagy-dependent ferroptosis by activating the AMPK/mTOR pathway in melanoma.
Wang M; Zeng G; Xiong B; Zhu X; Guo J; Chen D; Zhang S; Luo M; Guo L; Cai L
Biochem Pharmacol; 2023 Jun; 212():115554. PubMed ID: 37080437
[TBL] [Abstract][Full Text] [Related]
17. Glutathione peroxidase 4 inhibition induces ferroptosis and mTOR pathway suppression in thyroid cancer.
Sekhar KR; Hanna DN; Cyr S; Baechle JJ; Kuravi S; Balusu R; Rathmell K; Baregamian N
Sci Rep; 2022 Nov; 12(1):19396. PubMed ID: 36371529
[TBL] [Abstract][Full Text] [Related]
18. Upregulated Interleukin 21 Receptor Enhances Proliferation and Epithelial-Mesenchymal Transition Process in Benign Prostatic Hyperplasia.
Xu D; Chen P; Xiao H; Wang X; DiSanto ME; Zhang X
Front Endocrinol (Lausanne); 2019; 10():4. PubMed ID: 30728806
[No Abstract] [Full Text] [Related]
19. FTY720 induces ferroptosis and autophagy via PP2A/AMPK pathway in multiple myeloma cells.
Zhong Y; Tian F; Ma H; Wang H; Yang W; Liu Z; Liao A
Life Sci; 2020 Nov; 260():118077. PubMed ID: 32810509
[TBL] [Abstract][Full Text] [Related]
20. Rauwolfia vomitoria extract suppresses benign prostatic hyperplasia by inducing autophagic apoptosis through endoplasmic reticulum stress.
Huang G; He X; Xue Z; Long Y; Liu J; Cai J; Tang P; Han B; Shen B; Huang R; Yan J
BMC Complement Med Ther; 2022 May; 22(1):125. PubMed ID: 35513857
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
